Review maps expanding treatment options for hypertrophic cardiomyopathy, an inherited leading cause of sudden cardiac death in young adults
Reports and Proceedings
Updates every hour. Last Updated: 21-Oct-2026 17:17 ET (21-Oct-2026 21:17 GMT/UTC)
Hypertrophic cardiomyopathy (HCM), a predominantly inherited heart condition affecting roughly 1 in 500 people, remains the top cause of exercise‑related sudden cardiac death among young individuals. Traditional medications mostly relieve symptoms without targeting underlying disease mechanisms. This peer‑reviewed narrative review synthesizes global clinical trial and pre‑clinical evidence published between January 2010 and June 2026. Approved cardiac myosin‑inhibitor drugs reduce the need for invasive septal‑reduction procedures in many obstructive‑HCM patients. Multiple investigational metabolic, anti‑fibrotic, and gene‑editing therapies remain in early‑stage testing. Authors note that many promising approaches still lack large‑scale long‑term human outcome data before broad real‑world clinical adoption.
Heart failure represents a highly diverse global syndrome, and classification relying only on left‑ventricular ejection fraction cannot fully explain variable treatment responses, especially among patients with heart failure with preserved ejection fraction (HFpEF). This peer‑reviewed narrative review synthesizes published human clinical evidence from major databases up to December 2024. Authors describe five distinct HFpEF clinical phenotypes defined by comorbid conditions: metabolic, hypertensive, cardiorenal, pulmonary vascular, and inflammatory‑autoimmune subtypes. Each phenotype carries unique pathophysiology that may support phenotype‑specific therapy. The review notes that robust head‑to‑head treatment trials for these subgroups remain limited, calling for further prospective research before widespread real‑world adoption of precision‑based heart‑failure management.
Coronary artery disease remains the top global cause of death, yet current clinical practice often targets advanced vessel narrowing and ischemia, missing opportunities for early prevention before heart attacks occur. This peer‑reviewed commentary, inspired by The Lancet Commission, synthesizes real‑world Chinese population data showing atherosclerotic plaques are common among middle‑aged and older adults, with coronary plaque prevalence reaching 44.9% in local community cohorts aged 50‑75 years. The authors outline a stepwise, risk‑stratified screening workflow for primary‑care settings to detect subclinical plaque, prioritize systemic medical therapy over routine stenting for non‑culprit unstable lesions, and integrate inflammation and environmental risk control. The authors note that robust long‑term randomized trial evidence is still needed to validate broad implementation of plaque‑guided care.
Solar interfacial evaporation has undergone rapid development in recent years, yet its overall performance has reached a plateau due to limited advances in solar-thermal materials. Herein, we propose a synergistic nano-confinement and physical-field–modulation strategy that enables concurrent acceleration of solar-driven evaporation of water and on-site remediation of organic pollutants. Implemented in hollow mesoporous carbon nanocages integrated with Fe–N4 catalytic sites and inner wall plasmonic Au nanoparticles, the system couples mesoporous confinement with localized thermal and pressure perturbations to transform bulk water into thermodynamically activated intermediate states and substantially reduce the effective vaporization enthalpy. This integrated framework delivers high evaporation rates of 2.56 kg m−2 h−1 in planar devices and 6.84 kg m−2 h−1 in 3D architectures under one-sun irradiation, with a kinetic enhanced Hertz–Knudsen–Schrage–derived evaporation coefficient. Simultaneously, the Fe–N4 sites enable non-radical peroxymonosulfate activation for ultrafast degradation of bisphenol A, achieving a rate of 182.5 L g−1 min−1. This work establishes an ingenious strategy for coupling water-state regulation and catalytic pollutant degradation to break the performance bottleneck of solar-thermal purification.
Photodynamic therapy is attractive but often compromised by tissue hypoxia. We report a photosensitizer homodimer fission mechanism that produces photosensitizer radical ion pairs without exogenous redox substrates. These pairs enable coupled water oxidation and oxygen reduction, establishing a self-oxygen-supplying reactive oxygen species (ROS) cycle. By sustaining ROS generation under hypoxia, this strategy offers a new route to overcome the longstanding oxygen limitation of conventional photodynamic therapy.
APG V, the fifth community-based classification of flowering plants, has been published as an open-access review in Journal of Systematics and Evolution 64(5): 845–874 (2026) and is available at https://www.jse.ac.cn/EN/10.1111/jse.70096. Compiled by the Angiosperm Phylogeny Group, this phylogeny integrates hundreds of nuclear and plastid genes and marks a shift from mainly plastid-based classification to nuclear-genome-informed systematics.
Direct photocatalytic oxidation of methane to methanol under ambient pressure offers an attractive route for C1 valorization, yet it remains challenged by the competing requirements of activating inert C–H bonds while preventing methanol overoxidation. Here, a WO3/BN interface is reported that addresses this activity-selectivity trade-off by regulating the balance of reactive oxygen species. Interfacial coupling with BN promotes hole extraction from WO3 and induces electron accumulation in the WO3 domains, thereby preferentially enhancing ·OOH generation and increasing the ·OOH/·OH ratio. The elevated ·OOH/·OH ratio balances methane activation and methanol formation. Specifically,·OOH radicals facilitate C–H bond activation in methane, whereas ·OH radicals react with the resulting *CH3 intermediates to form methanol. The optimized WO3/BN-1:1 catalyst achieves a CH3OH production rate of 741.6 µmol/(g·h), nearly twice that of pristine WO3, with a CH3OH selectivity of 77.2% under ambient-pressure conditions. This work provides insights into regulating reactive oxygen species through interface engineering for the selective photocatalytic conversion of methane.
As a key strategy for reducing CO2 emissions, carbon capture and utilization (CCU) has gained increasing attention in the global pursuit of carbon neutrality and decarbonization. In particular, using a single material to achieve both efficient CO2 capture and photocatalytic CO2 conversion, thereby converting CO2 into high-value-added products, represents an attractive strategy. Such an integrated design can not only simplify the process flow and reduce energy consumption and costs, but also minimize losses associated with intermediate steps through in situ conversion, significantly improving overall carbon utilization efficiency. Metal–organic frameworks (MOFs) are porous crystalline materials that can not only serve as physical adsorbents for CO2 capture but also enable chemisorption through the rational design and optimization of secondary building units, organic linkers, and pore environments. Additionally, by engineering their electronic structures to optimize band structures and charge transport pathways, MOFs can serve as highly promising photocatalysts. Considerable progress has been made in the application of MOFs for CO2 capture and conversion. However, significant advances are still needed in the development of integrated MOFs-based systems that combine CO2 capture, enrichment, and in situ photocatalytic conversion. To accelerate progress in this area, a detailed review of recent developments is particularly important. Therefore, this review summarizes recent advances in MOFs-based materials for CCU, with particular emphasis on strategies for enhancing both CO2 capture and photocatalytic CO2 conversion. Finally, it discusses the current challenges and future research directions for developing integrated MOFs-based CCU systems.